Literature DB >> 29796863

Chronic Urticaria: Comparisons of US, European, and Asian Guidelines.

S Shahzad Mustafa1,2, Mario Sánchez-Borges3.   

Abstract

PURPOSE OF REVIEW: Chronic urticaria is a common dermatological condition that has significant impact on quality of life. Multiple international societies have published guidelines, and although these guidelines generally agree on the definition of urticaria, as well as approach to diagnosis and management, there have been notable differences to date. These differences have been reconciled by the recent publication of the 2017 revision and update published by the EAACI/GA2LEN/EDF/WAO. RECENT
FINDINGS: The 2017 revision and update to the guidelines for chronic urticaria are the most comprehensive consensus document to date, and reconcile previously existing differences between the US, European, and Asian guidelines. The purpose of our review is to present basic background on urticaria and discuss classification, diagnosis, and most importantly, management. We present differences from previous US, European, and Asian guidelines and reconcile the previous differences by summarizing the 2017 revision and update published by the EAACI/GA2LEN/EDF/WAO.

Entities:  

Keywords:  2017 revision and update; Angioedema; Diagnosis of urticaria; Hives; Management of urticaria; Urticaria; Urticaria activity score; Urticaria guidelines; Urticaria treatment algorithm

Mesh:

Year:  2018        PMID: 29796863     DOI: 10.1007/s11882-018-0789-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  49 in total

1.  Epidemiology of urticaria: a representative cross-sectional population survey.

Authors:  T Zuberbier; M Balke; M Worm; G Edenharter; M Maurer
Journal:  Clin Exp Dermatol       Date:  2010-12       Impact factor: 3.470

2.  A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.

Authors:  Sarbjit Saini; Karin E Rosen; Hsin-Ju Hsieh; Dennis A Wong; Edward Conner; Allen Kaplan; Sheldon Spector; Marcus Maurer
Journal:  J Allergy Clin Immunol       Date:  2011-07-18       Impact factor: 10.793

3.  Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.

Authors:  Karsten Weller; Adriane Groffik; Martin K Church; Tomasz Hawro; Karoline Krause; Martin Metz; Peter Martus; Thomas B Casale; Petra Staubach; Marcus Maurer
Journal:  J Allergy Clin Immunol       Date:  2014-02-09       Impact factor: 10.793

4.  Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.

Authors:  P C Potter; A Kapp; M Maurer; G Guillet; A M Jian; P Hauptmann; A Y Finlay
Journal:  Allergy       Date:  2008-11-11       Impact factor: 13.146

Review 5.  Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.

Authors:  Marek L Kowalski; Katharine Woessner; Marek Sanak
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

6.  Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.

Authors:  T Zuberbier; A Oanta; E Bogacka; I Medina; F Wesel; P Uhl; I Antépara; I Jáuregui; R Valiente
Journal:  Allergy       Date:  2009-10-23       Impact factor: 13.146

7.  Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.

Authors:  E Nettis; M C Colanardi; M T Paradiso; A Ferrannini
Journal:  Clin Exp Allergy       Date:  2004-09       Impact factor: 5.018

8.  Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials.

Authors:  Zuo-Tao Zhao; Chun-Mei Ji; Wen-Jun Yu; Ling Meng; Tomasz Hawro; Ji-Fu Wei; Marcus Maurer
Journal:  J Allergy Clin Immunol       Date:  2016-03-31       Impact factor: 10.793

9.  Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients.

Authors:  E Paul; R H Bödeker
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review.

Authors:  Gabriele Di Lorenzo; Alberto D'Alcamo; Manfredi Rizzo; Maria Stefania Leto-Barone; Claudia Lo Bianco; Vito Ditta; Donatella Politi; Francesco Castello; Ilenia Pepe; Gaetana Di Fede; Giovambattista Rini
Journal:  J Asthma Allergy       Date:  2008-12-09
View more
  12 in total

1.  The association of chronic spontaneous urticaria (CSU) with anxiety and depression: a nationwide cohort study.

Authors:  Dana Tzur Bitan; Daniella Berzin; Arnon Cohen
Journal:  Arch Dermatol Res       Date:  2020-04-08       Impact factor: 3.017

2.  Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.

Authors:  Elizabeth García-Gómez; Edgardo Chapman; María Beatriz García-Paba; Jaime Ocampo-Gómez; Eduardo Egea-Bermejo; Gloria Garavito-De Egea; Luis Fang; Mauricio Sarrazola; Jorge Mario Sánchez-Caraballo; Carlos Serrano-Reyes; Diana Lucia Silva-Espinosa; Dolly Vanessa Rojas-Mejía; Sergio M Moreno
Journal:  Front Allergy       Date:  2022-05-20

3.  Acupoint catgut embedding for patients with chronic urticaria: A systematic review protocol.

Authors:  Yunzhou Shi; Tinghui Hou; Qianhua Zheng; Ying Liu; Ting Yang; Ying Li
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

4.  Systematic reviews of pharmacological and nonpharmacological treatments for patients with chronic urticaria: An umbrella systematic review.

Authors:  Yunzhou Shi; Siyuan Zhou; Qianhua Zheng; Ying Huang; Pingsheng Hao; Mingmin Xu; Leixiao Zhang; Xianjun Xiao; Hui Zheng; Ying Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  VAS for assessing the perception of antihistamines use in allergic rhinitis.

Authors:  Giorgio Ciprandi; Ignazio La Mantia
Journal:  Acta Biomed       Date:  2019-07-03

6.  Behavior of Nutritional Supplements Use in Association With Inflammatory Skin Diseases in Chinese College Students.

Authors:  Yan Yuan; Juan Su; Ji Li; Juan Tao; Xiaojing Kang; Bin Wu; Shijun Shan; Xiaohui Wang; Xiang Chen; Minxue Shen; Liyuan Jiang
Journal:  Front Nutr       Date:  2021-03-17

Review 7.  The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations.

Authors:  Mario Sánchez-Borges; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan Bernstein; Giorgio Walter Canonica; Motohiro Ebisawa; R Maximiliano Gomez; Sandra González-Diaz; Bryan Martin; Mário Morais de Almeida; Jose Antonio Ortega Martell
Journal:  World Allergy Organ J       Date:  2021-06-03       Impact factor: 4.084

8.  Acupoint injection of Bacillus Calmette-Guerin polysaccharide nucleic acid for patients with chronic urticaria: A protocol for systematic review.

Authors:  Wei Cao; Xianjun Xiao; Leixiao Zhang; Lu Wang; Qianhua Zheng; Siyuan Zhou; Ying Liu; Yue Cao; Mingling Chen; Chunxiao Li; Ying Li
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

9.  Multi-center study for acupuncture combined with Chinese medicine in the treatment of chronic spontaneous urticaria based on the theory of taking shu-stream points when the disease is aggravated.

Authors:  Yuesi Qin; Jing Guo; Pan Song; Tianshu Hou; Yan He; Ming Han; Qianying Yu; Wenxia Lin; Mingling Chen; Hong Su
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

10.  Compound glycyrrhizin combined with antihistamines for chronic urticaria: A protocol for systematic review and meta analysis.

Authors:  Wei Cao; Xianjun Xiao; Leixiao Zhang; Ying Liu; Lu Wang; Zihao Zou; Yue Cao; Chunxiao Li; Qianhua Zheng; Siyuan Zhou; Ying Li
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.